Patel claims that he has developed a stable form of NAD+, but given its constraints with oral consumption, he is conducting extensive research on optimizing delivery, focusing on topical, sublingual, and nasal delivery
Studies show that after stopping GLP-1 medications, participants regain a significant portion of the weight they initially lost in some trials, about two-thirds within a year
Comparative effects of glucose-lowering medications on kidney outcomes in type 2 diabetes: the GRADE randomized clinical trial
Most side effects are gastrointestinal and tend to diminish as the dose is gradually increased
It reduces the appearance of fine lines, creases, and sagginess by stimulating collagen production and delaying the onset of premature wrinkles